指南与共识创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

脑损伤指南1级和2级创伤性脑损伤患者早期静脉血栓栓塞预防:一项5年分析

Early Venous Thromboembolism Prophylaxis in Brain Injury Guidelines 1 and Brain Injury Guidelines 2 Traumatic Brain Injury Patients: A 5-Year Analysis.
指南 / 共识 · J Trauma Acute Care Surg · 2025-05-01
一句话结论BIG 1或BIG 2创伤性脑损伤住院患者中,≤24小时启动静脉血栓栓塞预防与深静脉血栓风险降低相关,且未增加颅内出血进展或死亡风险。

该研究为单中心回顾性分析,纳入2017—2021年该一级创伤中心收治的、按脑损伤指南(BIG)分类为BIG 1或BIG 2且接受血栓预防的成人创伤性脑损伤患者634例,按启动时机分为早期组(≤24小时,393例)和晚期组(>24小时)。早期组深静脉血栓发生率低于晚期组(1% vs 5%,P=0.020),肺栓塞(P=0.620)和死亡(P=0.265)无差异;因神经功能恶化复查头颅CT者仅20例,两组无差异(P=0.398),且均无较基线头颅CT恶化。多变量回归显示早期血栓预防与深静脉血栓风险降低相关(校正OR 0.341,95%CI 0.121-0.783,P=0.043),与复查头颅CT(P=0.219)和死亡(P=0.653)无关。作者认为BIG 1或BIG 2患者早期血栓预防是安全的,但需未来研究验证其风险获益比。

要点

  • BIG 1或BIG 2成人创伤性脑损伤患者中,≤24小时启动静脉血栓栓塞预防者深静脉血栓发生率1%,>24小时启动者为5%(P=0.020)。
  • 早期血栓预防与深静脉血栓风险降低独立相关(校正OR 0.341,95%CI 0.121-0.783,P=0.043)。
  • 早期与晚期启动组肺栓塞(P=0.620)和死亡(P=0.265)无差异。
  • 因神经功能恶化复查头颅CT者仅20例,两组无差异(P=0.398),均无较基线头颅CT恶化。
  • 作者认为BIG 1或BIG 2患者早期血栓预防安全,但需未来研究验证风险获益比。

适用人群与场景

  • 2017—2021年单中心一级创伤中心创伤性脑损伤数据库中,按BIG分类为BIG 1或BIG 2且接受血栓预防的成人创伤患者。
  • 纳入因非创伤性脑损伤相关创伤住院的BIG 1或BIG 2患者。

研究设计与关键结果

  • 研究类型:单中心回顾性分析,2017—2021年数据库,共纳入634例,平均年龄42岁,男性62%,平均收缩压129 mm Hg,中位ISS 13。
  • 分组:早期组(≤24小时启动静脉血栓栓塞预防)393例,晚期组(>24小时启动)为其余患者。
  • 复查头颅CT:仅20例因神经功能恶化行复查头颅CT,两组无差异(P=0.398),均无较基线头颅CT恶化。
  • 深静脉血栓:早期组1% vs 晚期组5%(P=0.020);肺栓塞两组无差异(P=0.620);死亡两组无差异(P=0.265)。
  • 多变量回归:早期血栓预防与深静脉血栓风险降低相关(校正OR 0.341,95%CI 0.121-0.783,P=0.043),与复查头颅CT(P=0.219)和死亡(P=0.653)无关。

证据类型、等级与局限

  • 证据类型:单中心回顾性分析;证据等级:治疗/护理管理,Level IV。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为BIG 1或BIG 2创伤性脑损伤患者早期(≤24小时)静脉血栓栓塞预防是安全的,与深静脉血栓风险降低相关,且不增加颅内出血进展或死亡风险。
  • 作者指出需未来研究验证BIG 1和BIG 2患者血栓预防的风险获益比。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Brain Injury Guidelines (BIG) was developed to reduce hospitalization of patients with mild traumatic brain injury (TBI). Limited data on venous thromboembolism (VTE) prophylaxis for patients were categorized as BIG 1 and BIG 2 hospitalized for non-TBI-related trauma. The aim of this study is to assess safety of early VTE prophylaxis among BIG 1 and BIG 2 patients. We hypothesize that early VTE prophylaxis is safe.

METHODS: We performed retrospective analysis of 2017-2021 TBI database at our level 1 trauma center and included all adult trauma patients with TBI categorized as BIG 1 or BIG 2 who received thromboprophylaxis. Patients were stratified into EARLY (≤24 hours) and LATE (>24 hours) initiation of VTE prophylaxis. Outcomes were rates of repeat head computed tomography (RHCT) scan for neurological deterioration, mortality, deep vein thrombosis (DVT), and pulmonary embolism. Multivariable logistic regression was performed to identify independent effect of timing of VTE prophylaxis on outcomes.

RESULTS: A total of 634 met the inclusion criteria. The mean age was 42, 62% were males, the mean systolic blood pressure was 129 mm Hg, and the median ISS was 13. There were 393 patients in EARLY group. Only 20 patients underwent RHCT with no difference between the groups ( p = 0.398), with no worsening from index head CT. EARLY group had lower incidence of DVT (EARLY: 1% vs. LATE: 5%, p = 0.020) but no difference in pulmonary embolism ( p = 0.620) or mortality ( p = 0.265). On multivariable regression analysis, early VTE prophylaxis was associated with reducing risk of DVT (adjusted odds ratio, 0.341; 95% confidence interval, 0.121-0.783; p = 0.043). However, it was not associated with RHCT ( p = 0.219) or mortality ( p = 0.653).

CONCLUSION: Early thromboprophylaxis for BIG 1 or BIG 2 trauma patients is safe and associated with reducing DVT risk without increasing risk of ICH progression or mortality. Future studies are needed to validate thromboprophylaxis risk-benefit ratio among BIG 1 and BIG 2 patients.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Villarin Ayala S, Hejazi O, Al Ma'ani M, et al. Early Venous Thromboembolism Prophylaxis in Brain Injury Guidelines 1 and Brain Injury Guidelines 2 Traumatic Brain Injury Patients: A 5-Year Analysis. J Trauma Acute Care Surg. 2025. PMID: 40307971. doi:10.1097/TA.0000000000004647

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。